All News

Eric C. Schneider, MD, senior principal researcher and distinguished chair in health care quality at RAND, and director of its Boston office, will join The Commonwealth Fund as senior vice president for policy and research on February 2, 2015.

Medical technology hazards remain a top safety issue for hospitals and can come in many forms. However, for the fourth year in a row, alarm hazards topped the annual Top 10 Health Technology Hazards list from the ECRI Institute.

Following on the heels of the FDA's advice on the risk of using morcellators for treating fibroids, researchers in France have released results of a study that delineates a method that can avoid the risk of morcellating a pre-existing uterine sarcoma.

Physicians who receive higher reimbursements for routine office visits are more likely to perform cancer screening tests on Medicaid beneficiaries, according to a new study in Cancer.

The ACO and Emerging Healthcare Delivery Coalition, an initiative of The American Journal of Managed Care, held its most recent WebEx session this week. Participants discussed new strategies and technologies that both employers and healthcare organizations can use to get patients to take ownership over their own care.

Few employers are planning to eliminate their health benefits in 2015, but they are still looking to make noticeable changes, according to a report from the Employee Benefit Research Institute.

The study, published in PNAS, identified a gene whose expression could be used as a prognostic indicator and could direct treatment in breast cancer patients.

Amid last week's news that CMS had miscalculated the number of enrollees under the Affordable Care Act was a quieter announcement that the agency had appointed a chief data office to improve transparency, among other tasks.

The deadline for eligible hospitals and critical access hospitals to attest to meeting meaningful use requirements has been pushed back a full month, according to CMS.

Genentech's decision to use a handful of specialty drug distributors instead of wholesalers for the distribution of the most commonly used anticancer medications has raised concerns of availability and cost.

The large retrospective study, conducted in 9.8 million men, identified a strong association between obesity and the development of an advanced and more aggressive form of the disease.

In the first 2 years of the Affordable Care Act, open enrollment has run for 2 different time periods, and HHS is looking to set a fixed date for future years. Plus, it offers a solution to automatic re-enrollment.

The monoclonal antibody,a c-Met inhibitor, was being tested in advanced gastric cancer patients following it's revival 2 years back.

The disclosure that a calculation error caused the Obama administration to add an extra 400,000 people to ACA enrollment figures for months puts a dent in the 2015 open enrollment, in part because it fits a narrative of a lack of transparency for reporters who cover the administration.

In the update, the FDA is now asking the device manufacturers to include a black box warning and contraindications, to warn both providers and patients of possible health risks with the procedure.

This article in The New York Times details the reasons why private oncology practices are being forced to consolidate to stay afloat.

Laws allowing terminal patients to try drugs not approved by the FDA have passed in five states, but experts question their efficacy.

The study, published in Nature Medicine, identified a small molecule inhibitor that increases histone methylation, compensating for the reduced methylation caused by mutation in the H3F3A gene, resulting in gliomas.

The leaders of the United Nations and the World Health Organization expressed renewed alarm on Friday about Ebola's tenacity in Africa and, in particular, its potential to ravage a fourth country, Mali, where they said hundreds of people had been exposed to an infected cleric who died last month.

Researchers at Vanderbilt University Medical Center have used electronic health record analysis to uncover hidden drug benefits, according to a study appearing in the Journal of the American Medical Informatics Association.

A HIPAA-compliant app developed by doctors at the Arnold Palmer Hospital for Children in Orlando, helps quell the anxiety of family members as their children undergo surgery.

Champions Oncology will be presenting data on it's preclinical model at the ongoing EORTC-NCI-AACR Symposium in Barcelona. The model proposes to help develop individualized treatments for patients.

In March, the Obama administration released guidance extending the renewal of health insurance policies that do not meet the Affordable Care Act's coverage standards through October 1, 2016. At least 9 states that did not adopt the administration's original transitional policy are now allowing renewals of noncompliant policies after January 1, 2014.

Randomized trials are highly effective for suggesting ways to improve healthcare delivery, but they're also rare. That may be changing.

Republicans finally filed a lawsuit against President Obama's healthcare reform law, the Affordable Care Act, after approving the suit in July. They are challenging the employer-based coverage aspect of the law, as well as Treasury payments to insurers.

Scientists at the Memorial Sloan Kettering Cancer Center have identified that tumor mutation burden could help predict responders to ipilimumab treatment. The report has been published online in the New England Journal of Medicine.

A recent study published in European Urology highlights quality-of-life benefits with active surveillance in men with prostate cancer.

Vermont Senator Bernie Sanders has introduced a bill that would require generic drugmakers to pay rebates to the federal Medicare and Medicaid programs when prices of their medications outpace inflation.

The study, published in Cell Reports, evaluates the dynamic protein interactions that promote different diseases including cancer. By capturing these interactions, the authors hope to discover new drug targets.

A new study shows only a small share of patients with private insurance who were newly diagnosed with diabetes in 2011-2012 enrolled in self-management training, raising questions about how well managed care could address both long-term health and cost control for this important group. These patients are a target for special attention under the ACA.